Concepedia

Author

David Ketteridge

Women's and Children's Hospital

Also Known As

D KETTERIDGE, D. Ketteridge, D.S. Ketteridge, David Ketteridge

42

Publications

2K

Citations

21

H-Index

45

Concepts

All Affiliations

Women's and Children's HospitalBioMarin (United States)Universidade Federal do Rio Grande do SulHospital de São JoãoSouth Australia Pathology
DK

About

David Ketteridge is an author at Women's and Children's Hospital specializing in medicine, pathology, and lysosomal storage disease.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

7

7

420

2

Health Sciences

1

1

68

3

Public Health

1

1

68

4

Social Sciences

1

1

24

5

Applied Physiology

1

1

68

David Ketteridge

×

24

Publications

1.9K

Citations

20

H-Index

YearCitations

Long-term follow-up of endurance and safety outcomes during enzyme replacement therapy for mucopolysaccharidosis VI: Final results of three clinical studies of recombinant human N-acetylgalactosamine 4-sulfatase

Paul Harmatz, Roberto Giugliani, Ida Vanessa Döederlein Schwartz,

Molecular Genetics and Metabolism

2008

215

Direct Comparison of Measures of Endurance, Mobility, and Joint Function During Enzyme-Replacement Therapy of Mucopolysaccharidosis VI (Maroteaux-Lamy Syndrome): Results After 48 Weeks in a Phase 2 Open-Label Clinical Study of Recombinant Human <i>N</i>-Acetylgalactosamine 4-Sulfatase

Paul Harmatz, David Ketteridge, Roberto Giugliani,

PEDIATRICS

2005

213

Clinical presentation and outcome in a series of 88 patients with the cblC defect

Sabine Fischer, Martina Huemer, Matthias R. Baumgartner,

Journal of Inherited Metabolic Disease

2014

165

Threshold effect of urinary glycosaminoglycans and the walk test as indicators of disease progression in a survey of subjects with Mucopolysaccharidosis VI (Maroteaux-Lamy syndrome)

Stuart J. Swiedler, Michael Beck, M Bajbouj,

American Journal of Medical Genetics Part A

2005

161

SURF1 deficiency: a multi-centre natural history study

Yehani Wedatilake, Ruth M. Brown, Robert McFarland,

Orphanet Journal of Rare Diseases

2013

133

Mutational analysis of 105 mucopolysaccharidosis type VI patients

Litsa Karageorgos, Doug A. Brooks, A.C. Pollard,

Human Mutation

2007

132

Diagnosing mucopolysaccharidosis IVA

Timothy C. Wood, Katie Harvey, Michael Beck,

Journal of Inherited Metabolic Disease

2013

98

Natural history and galsulfase treatment in mucopolysaccharidosis VI (MPS VI, Maroteaux–Lamy syndrome)—10‐year follow‐up of patients who previously participated in an MPS VI survey study

Roberto Giugliani, Christina Lampe, Nathalie Guffon,

American Journal of Medical Genetics Part A

2014

98

Enzyme replacement therapy for mucopolysaccharidosis VI: evaluation of long‐term pulmonary function in patients treated with recombinant human <i>N</i>‐acetylgalactosamine 4‐sulfatase

Paul Harmatz, Zi‐Fan Yu, Roberto Giugliani,

Journal of Inherited Metabolic Disease

2010

91

Chagas's disease in the Amazon Basin: II. The distribution of Trypanosoma cruzi zymodemes 1 and 3 in Pará State, north Brazil

Michael A. Miles, Marinete Marins Póvoa, A. A. de Souza,

Transactions of the Royal Society of Tropical Medicine and Hygiene

1981

88

Page 1